Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
49m
RSV prophylactic market to reach $6.2bn in 8MM by 2030
Six products in late-stage development have the potential to launch by 2030. Credit: MargJohnsonVA via Shutterstock. · ...
Targeted Oncology
39m
Sonrotoclax and Zanubrutinib Shows Strong Efficacy in Untreated CLL/SLL
Initial therapy with sonrotoclax and zanubrutinib showed strong efficacy and acceptable safety in untreated CLL/SLL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Murder suspect charged
Tyson faces $1.5M suit
Cardiovascular disease risk
Targeted by a bomb threat
On birthright citizenship
Syria's chemical weapons hit
Seek Senate support
US renews push to find Tice
CA warnings on social sites
Alaska oil & gas auction set
Hawaii gun case rejected
Emergency brain surgery
Orbán meets Trump, Musk
Women drop lawsuit
Read's second trial delayed
Wildfire forces evacuations
NFL streaming record set
Deputy secretary of state
Famed poet Giovanni dies
X removes image generator
Trust restructuring fails
Set to take witness stand
2024 best-managed firms
ISR warplanes pound Syria
Judge reviews Infowars sale
Launches AI video generator
Osprey flights paused again
TN grabs No. 1 in AP Top 25
NJ mayors seek drone info
NJ fines sports betting firms
US indicts ex-Syrian officials
Feedback